Ritvo PG , Fischer JS , Miller DM , Andrews H , Paty D , LaRocca NG.Multiple sclerosis quality of life inventory: a user’s manual. New York, NY: National Multiple Sclerosis Society , 1997.
2.
Guyatt GH , Jaeschke R , Feeny DH , Patrick DL.Measurements in clinical trials: choosing the right approach. In Spilker B ed. Philadelphia, PA: Lippincott-Raven , 1996: 41-48.
3.
Rothwell PM.Quality of life in multiple sclerosis [editorial; comment] . J Neurol Neurosurg Psychiatry1998; 65: 433-433 .
4.
Freeman JA , Langdon DW , Hobart JC , Thompson AJ.Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?Neurology1999; 52: 50-56 .
5.
World Health Organization . International classification of impairments, disabilities and handicaps (ICIDH): a manual for classification. Geneva: WHO , 1980.
6.
Schipper H , Clinch JJ , Olweny CLM.Quality of life studies: definitions and conceptual issues. In Spilker B ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven , 1996: 11-24.
7.
Schwartz CE , Coulthard-Morris L , Cole B , Vollmer T.The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiSTanalysis . Arch Neurol1997; 54: 1475-1480 .
8.
Rice GP , Oger J , Duquette P , et al.Treatment with interferon beta-1b improves quality of life in multiple sclerosis . Can J Neurol Sci1999; 26: 276-282 .
9.
Nortvedt MW , Riise T , Myhr KM , Nyland HI , Hanestad BR.Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a . Mult Scler1999; 5: 317-322 .
10.
Arnoldus JH , Killestein J , Pfennings LE , Jelles B , Uitdehaag BM , Polman CH.Quality of life during the first 6 months of interferon-beta treatment in patients with MS . Mult Scler2000; 6: 338-342 .
11.
Freeman JA , Thompson AJ , Fitzpatrick R , et al.Interferon-Beta1b in the treatment of secondary progressive MS: impact on quality of life . Neurology2001; 57(Suppl 2): 1870-1875 .
12.
Petajan JH , Gappmaier E , White AT , Spencer MK , Mino L , Hicks RW.Impact of aerobic training on fitness and quality of life in multiple sclerosis [see comments] . Ann Neurol1996; 39: 432-441 .
13.
Gianino JM , York MM , Paice JA , Shott S.Quality of life: effect of reduced spasticity from intrathecal baclofen . J Neurosci Nurs1998; 30: 47-54 .
14.
Solari A , Filippini G , Gasco P , et al.Physical rehabilitation has a positive effect on disability in multiple sclerosis patients [see comments] . Neurology1999; 52: 57-62 .
15.
Shawaryn MA , Schiaffino KM , LaRocca NG , Johnston MV.Determinants of health-related quality of life in multiple sclerosis: the role of illness intrusiveness . Mult Scler2002; 8: 310-318 .
16.
Devins GM , Binik YM , Hutchinson TA , Hollomby DJ , Barre PE , Guttmann RD.The emotional impact of end-stage renal disease: importance of patients’ perception of intrusiveness and control . Int J Psychiatry Med1983; 13: 327-343 .